Malaria
Feature stories
May 20, 2009
Life-saving research rewarded
Scientists who developed Novartis Coartem and Glivec receive 2009 "European Inventor of the Year" awards.
April 24, 2009
Novartis in the fight against malaria
April 25 is World Malaria Day, an opportunity to reflect on the progress made in finding sustainable solutions for malaria.
December 18, 2008
NITD: Combating neglected tropical diseases
The Novartis Institute for Tropical Diseases aims to discover novel treatments and prevention methods for major tropical diseases.
April 25, 2008
Zambezi Expedition puts malaria in the spotlight
Novartis is part of a multi-agency partnership supporting an ambitious journey along the Zambezi River, highlighting the difficulty of delivering mosquito nets and malaria treatment to remote African communities.
March 19, 2008
NVGH blazes a trail: Effective and affordable vaccines for the developing world
Many eminent scientists are contributing to the Novartis Vaccines Institute for Global Health, the first research center established by a major vaccine manufacturer with a nonprofit mission - to discover and develop vaccines for “neglected” diseases of the developing world.
August 13, 2007
NITD: Rejuvenating Research in Neglected Diseases
The Novartis Institute for Tropical Diseases (NITD), part of Novartis Corporate Research, set out five years ago to apply leading-edge tools of biomedical research to tropical diseases such as dengue fever and tuberculosis that take a daunting toll among patients in the developing world.
April 17, 2007
Coartem in Africa: Gaining Momentum on the Ground
The main battleground is Africa, where malaria kills more than a million people every year, mainly pregnant women and children younger than five years of age. “Malaria is more than an ordinary disease on this continent,” says the Honorable Richard Nduhura, Uganda’s Minister of State for Health.
Corporate Citizenship
Corporate citizenship at Novartis is an integral part of how we operate and a key to our success.
